Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05454267 · ClinicalTrials.gov registry record
Early Detection of Vaping-related Vascular Diseases
A clinical trial of Vaping and Blood Vessel Injury, sponsored by University of Miami.
- Recruiting
- Registry status
- 90
- Enrollment target
- 1
- Study location
NCT05454267: Recruiting study of Vaping and Blood Vessel Injury, sponsored by University of Miami.
NCT05454267 is a study of Vaping and Blood Vessel Injury that is actively recruiting participants, run by University of Miami. The registered enrollment target is 90 participants, below the 756-participant average among 18 other Vaping trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05454267, a study of Vaping and Blood Vessel Injury, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.
Primary Outcome
QAW will be measured via soluble gas uptake method
Conditions Studied
Study Locations (1)
Florida
- University of Miami Health System - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2026-12-31 |
What NCT05454267 shows while recruiting
NCT05454267 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 756-participant average among 18 other Vaping trials with a reported enrollment target (88% lower).
The record links to 2 conditions, with Vaping appearing as the primary indexed condition, and to 0 interventions.
NCT05454267 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT05454267 about?
NCT05454267 is a clinical study titled "Early Detection of Vaping-related Vascular Diseases". The purpose of this study is to determine how vaping affects blood vessels, in particular if early damage occurs in the lung vessels.
What is the current status of trial NCT05454267?
This trial is currently recruiting. The enrollment target is 90 participants. The study started on 2022-09-12. Estimated completion is 2026-12-31.
What conditions does trial NCT05454267 study?
This clinical trial studies the following conditions: Vaping, Blood Vessel Injury.
Who is sponsoring clinical trial NCT05454267?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05454267 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vaping
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05454267's enrollment target sits among peer trials
90 13th of 18 higher than 6 of 18 other Vaping trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vaping trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Non-invasive Vagus Nerve Stimulation (nVNS) and Cognition in Young Adult Vapers - A Pilot Study
RECRUITING · NA
-
Perceived Effectiveness of Vaping Prevention Ads Among Adolescents and Young Adults
RECRUITING · NA
-
A Trial of Varenicline for E-cigarette Cessation
RECRUITING · Phase 2
-
Vape Use Among Younger & Older Smokers
RECRUITING
-
Secondhand Effects of Hookah (i.e., Waterpipe) Smoke and Aerosol
RECRUITING · NA
-
Behavioral Intervention for Youth to Promote Vaping Cessation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI